Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Rammaert, Blandine ^a   Couderc, Louis Jean ^b   Rivaud, Elisabeth ^b   Honderlick, Patrick ^c   Zucman, David ^c   Mamzer, Marie France ^a   Cahen, Pierre ^c   Bille, Emmanuel ^a   Lecuit, Marc ^a,d   Lortholary, Olivier ^a,d   Catherinot, Emilie ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c FOCH HOSPITAL   (France)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CLARITHROMYCIN; CYCLOSPORIN A; EFAVIRENZ; EMTRICITABINE; ETHAMBUTOL; GAMMA INTERFERON; ISONIAZID; MOXIFLOXACIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PYRAZINAMIDE; PYRIMETHAMINE; RIBOSOME DNA; RIFABUTIN; RIFAMPICIN; SULFADIAZINE; TACROLIMUS; TENOFOVIR; ANTIINFECTIVE AGENT;

ACID FAST BACTERIUM; ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BRAIN ABSCESS; CASE REPORT; CD4+ T LYMPHOCYTE; CELLULAR IMMUNODEFICIENCY; CHRONIC GRAFT REJECTION; COMPUTER ASSISTED TOMOGRAPHY; CYTODIAGNOSIS; DISEASE COURSE; DRUG DOSE INCREASE; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LUNG BIOPSY; LUNG CAVITATION; LUNG GRANULOMA; LUNG INFILTRATE; LUNG LAVAGE; LUNG NODULE; MALE; MESENTERIC LYMPHADENITIS; MYCOBACTERIOSIS; MYCOBACTERIUM GENAVENSE; NONHUMAN; OXYGEN THERAPY; PNEUMONIA; SPUTUM SMEAR; SUBACUTE PNEUMONIA; THORAX RADIOGRAPHY; TOXOPLASMOSIS; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS; ULCERATIVE COLITIS; VIRUS LOAD; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIAL PNEUMONIA; CLASSIFICATION; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOLOGY;

ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC DEFICIENCY SYNDROMES; KIDNEY TRANSPLANTATION; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PNEUMONIA, BACTERIAL;

EID: 80355132672     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-311     Document Type: Article

References (28)

1. Mortellaro A, Robinson L, Ricciardi-Castagnoli P. Spotlight on Mycobacteria and dendritic cells: will novel targets to fight tuberculosis emerge?. EMBO Mol Med 2009, 1(1):19-29. 10.1002/emmm.200900008, 20049700.
2. Glassroth J. Pulmonary disease due to nontuberculous mycobacteria. Chest 2008, 133(1):243-251. 10.1378/chest.07-0358, 18187749.
3. Hillebrand-Haverkort ME, Kolk AH, Kox LF, Ten Velden JJ, Ten Veen JH. Generalized mycobacterium genavense infection in HIV-infected patients: detection of the mycobacterium in hospital tap water. Scand J Infect Dis 1999, 31(1):63-68. 10.1080/00365549950161907, 10381220.
4. Manarolla G, Liandris E, Pisoni G, Sassera D, Grilli G, Gallazzi D, Sironi G, Moroni P, Piccinini R, Rampin T. Avian mycobacteriosis in companion birds: 20-year survey. Vet Microbiol 2009, 133(4):323-327. 10.1016/j.vetmic.2008.07.017, 18789612.
5. Bessesen MT, Shlay J, Stone-Venohr B, Cohn DL, Reves RR. Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy. AIDS 1993, 7(10):1357-1361. 10.1097/00002030-199310000-00009, 8267909.
6. Lu KJ, Grigg A, Leslie D, Finlay M, Sasadeusz J. Mycobacterium genavense duodenitis following allogeneic peripheral blood stem cell transplantation. Transpl Infect Dis 2009, 11(6):534-536. 10.1111/j.1399-3062.2009.00431.x, 19656345.
7. Bogdan C, Kern P, Richter E, Tannapfel A, Rusch-Gerdes S, Kirchner T, Solbach W. Systemic infection with Mycobacterium genavense following immunosuppressive therapy in a patient who was seronegative for human immunodeficiency virus. Clin Infect Dis 1997, 24(6):1245-1247. 10.1086/513634, 9195092.
8. Charles P, Lortholary O, Dechartres A, Doustar F, Viard J-P, Lecuit M, Gutierrez MC, Group T. Mycobacterium genavense Infections: a retrospective Multicenter Study between 1996 and 2007 in France. Medicine 2011, 90(4):223-30. 10.1097/MD.0b013e318225ab89, 21694645.
9. Tortoli E, Brunello F, Cagni AE, Colombrita D, Dionisio D, Grisendi L, Manfrin V, Moroni M, Passerini Tosi C, Pinsi G, et al. Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature. Eur J Epidemiol 1998, 14(3):219-224. 10.1023/A:1007401305708, 9663512.
10. Nurmohamed S, Weenink A, Moeniralam H, Visser C, Bemelman F. Hyperammonemia in generalized Mycobacterium genavense infection after renal transplantation. Am J Transplant 2007, 7(3):722-723. 10.1111/j.1600-6143.2006.01680.x, 17250553.
11. de Lastours V, Guillemain R, Mainardi JL, Aubert A, Chevalier P, Lefort A, Podglajen I. Early diagnosis of disseminated Mycobacterium genavense infection. Emerg Infect Dis 2008, 14(2):346-347. 10.3201/eid1402.070901, 2600216, 18258141.
12. Pechere M, Opravil M, Wald A, Chave JP, Bessesen M, Sievers A, Hein R, von Overbeck J, Clark RA, Tortoli E, et al. Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study. Arch Intern Med 1995, 155(4):400-404. 10.1001/archinte.155.4.400, 7848023.
13. Thomsen VO, Dragsted UB, Bauer J, Fuursted K, Lundgren J. Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists. J Clin Microbiol 1999, 37(12):3901-3905. 85841, 10565904.
14. Dumonceau JM, Van Gossum A, Adler M, Van Vooren JP, Fonteyne PA, De Beenhouwer H, Portaels F. Detection of fastidious mycobacteria in human intestines by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis 1997, 16(5):358-363. 10.1007/BF01726363, 9228475.
15. Delpire P, Farber CM, Portaels F, Struelens M, Clevenbergh P, Dargent JL, Delpace J, Mehdi A, Van Vooren JP. Splenectomy in a patients with AIDS, generalized Mycobacterium genavense infection and severe pancytopenia. Tuber Lung Dis 1996, 77(6):569-570. 10.1016/S0962-8479(96)90059-3, 9039454.
16. Krebs T, Zimmerli S, Bodmer T, Lammle B. Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukaemia. J Intern Med 2000, 248(4):343-348. 10.1046/j.1365-2796.2000.00730.x, 11086646.
17. Leautez S, Boutoille D, Bemer-Melchior P, Ponge T, Raffi F. Localized Mycobacterium genavense soft tissue infection in an immunodeficient HIV-negative patient. Eur J Clin Microbiol Infect Dis 2000, 19(1):51-52. 10.1007/s100960050010, 10706181.
18. Trueba F, Fabre M, Saint-Blancard P. Rapid identification of Mycobacterium genavense with a new commercially available molecular test, INNO-LiPA MYCOBACTERIA v2. J Clin Microbiol 2004, 42(9):4403-4404. 10.1128/JCM.42.9.4403-4404.2004, 516359, 15365056.
19. Ninet B, Rutschmann O, Burkhardt K, Metral C, Borisch B, Hirschel B. Detection of mycobacterial nucleic acids by polymerase chain reaction in fixed tissue specimens of patients with human immunodeficiency virus infection. Swiss HIV Cohort Study. Diagn Mol Pathol 1999, 8(3):145-151. 10.1097/00019606-199909000-00007, 10565686.
20. Chevrier D, Oprisan G, Maresca A, Matsiota-Bernard P, Guesdon JL. Isolation of a specific DNA fragment and development of a PCR-based method for the detection of Mycobacterium genavense. FEMS Immunol Med Microbiol 1999, 23(3):243-252. 10.1111/j.1574-695X.1999.tb01245.x, 10219597.
21. Albrecht H, Rusch-Gerdes S, Stellbrink HJ, Greten H, Jackle S. Disseminated Mycobacterium genavense infection as a cause of pseudo-Whipple's disease and sclerosing cholangitis. Clin Infect Dis 1997, 25(3):742-743. 10.1086/516941, 9314476.
22. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002, 20:581-620. 10.1146/annurev.immunol.20.081501.125851, 11861613.
23. Matsiota-Bernard P, Vilde F, Nauciel C. Mycobacterium genavense infection in normal and immunodeficient mice. Microbes Infect 2000, 2(6):575-580. 10.1016/S1286-4579(00)00369-5, 10884607.
24. Catherinot E, Lanternier F, Bougnoux ME, Lecuit M, Couderc LJ, Lortholary O. Pneumocystis jirovecii Pneumonia. Infect Dis Clin North Am 24(1):107-138.
25. Vrioni G, Nauciel C, Kerharo G, Matsiota-Bernard P. Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin. J Antimicrob Chemother 1998, 42(4):483-487. 10.1093/jac/42.4.483, 9818747.
26. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175(4):367-416. 10.1164/rccm.200604-571ST, 17277290.
27. Ehlers S, Richter E. Gamma interferon is essential for clearing Mycobacterium genavense infection. Infect Immun 2000, 68(6):3720-3723. 10.1128/IAI.68.6.3720-3723.2000, 97665, 10816534.
28. Kedzierska K, Azzam R, Ellery P, Mak J, Jaworowski A, Crowe SM. Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J Clin Virol 2003, 26(2):247-263. 10.1016/S1386-6532(02)00123-3, 12600656.